The trademark application NX was filed by Navignostics AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on November 13, 2023, and it was registered by office on February 20, 2024 without any oppositions.
It was designated 'Basic Application' for International Application 1784862 at the World Intellectual Property Organization (WIPO).
The application was filed in English (German was selected as the second language).
A transfer of the trademark registration was recorded on March 19, 2024. Change of name and address of the trademark registration was recorded on April 14, 2024.
Goods And Services
The mark was filed in class 1 with following description of goods:
Diagnostic biomarkers for analytical, research and scientific use
Diagnostic biomarkers for in vitro testing for scientific use
Diagnostic biomarkers for use in assessment of genomic analysis for scientific use
Diagnostic biomarkers for use in assessment of individual diagnoses of cancer
Diagnostic preparations for science or research
Diagnostic reagents for science or research Diagnostic reagents for the diagnosis of diseases
Chemicals for the production of medical diagnostic reagents, particularly for cancer research.
The mark was filed in class 5 with following description of goods:
Reactants for medical diagnosis
Preparations for medical diagnosis
Diagnostic reagents for medical or veterinary use in in vitro diagnosis
Reactants for medical diagnosis, particularly for usage with spatial single-cell proteomics Reagents for diagnostic tests for medical use
Diagnostic test reagents for veterinary use
Diagnostic preparations for medical use
Diagnostic radiopharmaceutical preparations
Diagnostic substances for medical use
Pharmaceutical products, medical and veterinary preparations
Pharmaceuticals for the treatment of cancer
Pharmaceutical preparations and compositions for the treatment and prevention of cancer
Pharmaceutical preparations
Pharmaceutical preparations for the diagnosis of diseases
Pharmaceutical preparations for diagnosis
Pharmaceutical preparations for diagnostic purposes
Pharmaceutical preparations for individual medical diagnosis Pharmaceutical preparations for medical test kits
Pharmaceutical preparations for medical test kits for use in oncology
Pharmaceutical preparations for medical test kits for cancer diagnosis
Pharmaceutical preparations for medical test kits for individual medical diagnosis
Diagnostic test kits for use in oncology
Diagnostic test kits for cancer diagnosis
Diagnostic test kits for individual medical diagnosis.
The mark was filed in class 9 with following description of goods:
Recorded computer programs for use in cancer diagnosis
Downloadable computer programs for use in cancer diagnosis
Recorded computer programs for use in oncology
Downloadable computer programs for use in oncology
Downloadable software applications for Medical and scientific research in the field of cancer treatment and diagnosis
Downloadable and recorded computer programs using machine learning in the field of medical diagnosis and research, particularly for cancer research, treatment and diagnosis
Software for the analysis of medical data, particularly for cancer research, treatment and diagnosis
Software for the digital representation of tumors and tumor features
Software for high-resolution digital image representation of the molecular composition of cellular anomalies
Software for high-resolution digital image representation of a digital tumor
Downloadable and recorded computer programs using machine learning in the field of medical diagnosis and research, particularly for cancer research, treatment and diagnosis
Software for the analysis of medical data, particularly for cancer research, treatment and diagnosis.
The mark was filed in class 10 with following description of goods:
Apparatus for tumour diagnosis
Medical apparatus for machine learning-based spectrum analysis of human blood plasma
Scanners for medical diagnosis
Apparatus for clinical diagnosis, Spectrum analyzers for use in medical diagnosis
Trace material analyzers for medical use in diagnosis
Apparatus used in implementing diagnosis tests designed to detect abnormal genetic mutations in proteins
Diagnostic oncology apparatus for medical use
Diagnostic, examination, and monitoring equipment
Medical tests kits for the use in oncology
Medical test kits for cancer diagnosis
Medical test kits for individual medical diagnosis.
The mark was filed in class 42 with following description of goods:
Cancer research
Cancer diagnosis research
Research in the field of Proteomics
Oncological research
Research in the field of oncological diagnostics
Technical data analysis services
Development of personalized diagnostics products for cancer treatment
Software-as-a-Service [SaaS] for use in cancer diagnosis
Platform-as-a-Service [PaaS] for use in cancer diagnosis
Software-as-a-Service [SaaS] for use in oncology
Platform-as-a-Service [PaaS] for use in oncology
Software-as-a-Service [SaaS] for medical and scientific research in the field of cancer treatment and diagnosis
Platform-as-a-Service [PaaS] for medical and scientific research in the field of cancer treatment and diagnosis
Software-as-a-Service [SaaS] using machine learning in the field of medical diagnosis and research, particularly for cancer research, treatment and diagnosis
Platform-as-a-Service [PaaS] using machine learning in the field of medical diagnosis and research, particularly for cancer research, treatment and diagnosis
Software-as-a-Service [SaaS] for the analysis of medical data, particularly for cancer research, treatment and diagnosis
Platform-as-a-Service [PaaS] for the analysis of medical data, particularly for cancer research, treatment and diagnosis
Software as-a-Service [SaaS] for the digital representation of tumours and tumour features
Platform-as-a-Service [PaaS] for the digital representation of tumours and tumour features
Software as-a-Service [SaaS] for high-resolution digital image representation of the molecular composition of cellular anomalies
Platform-as-a-Service [PaaS] for high-resolution digital image representation of the molecular composition of cellular anomalies Software as-a-Service [SaaS] for high-resolution digital image representation of digital tumors
Platform-as-a-Service [PaaS] for high-resolution digital image representation of digital tumors.
The mark was filed in class 44 with following description of goods:
Pharmaceutical and diagnostical consulting, particularly in the field of oncology
Pharmaceutical and diagnostical consulting for businesses in the medical field
Pharmaceutical and consulting for cancer treatment
Disease diagnosis services
Cancer diagnosis services, particularly for enabling personalized and individual medical care
Disease diagnosis services, particularly in the field of oncology
Disease diagnosis services in the field of proteomics
Medical analysis services for cancer diagnosis and prognosis
Remote monitoring of medical data for medical diagnosis
Medical analysis for the diagnosis and treatment of persons
Remote monitoring of medical data for medical diagnosis and treatment
Medical testing services relating to the diagnosis and treatment of disease
Providing information in the field of cancer prevention, screening, diagnosis and treatment
Medical diagnosis and treatment of cancer
Medical diagnostic services (testing and analysis)
Medical diagnostic services for the indication of individual treatments
Medical diagnostic services for the indication of individual cancer treatments
Medical diagnostic services for the indication of individual treatments in the field of oncology
Providing information concerning diagnostic, prophylactic and therapeutic properties of pharmaceutical and biological products for prevention and treatment of diseases, disorders and conditions